Investor Presentation via Investor Meet Company

Summary by AI BETAClose X

Target Healthcare REIT PLC will host a live presentation regarding its Full Year Results on Investor Meet Company on October 28, 2025, at 10:00 am GMT. The presentation will be given by Kenneth MacKenzie, Alastair Murray, and James MacKenzie of Target Fund Managers. Existing and potential shareholders are invited to attend, and can submit questions in advance until 9:00 am GMT the day before the meeting, or during the live presentation. Interested parties can register for free on the Investor Meet Company platform to join the Target Healthcare REIT PLC presentation.

Disclaimer*

Target Healthcare REIT PLC
17 October 2025
 

To:                   RNS

From:               Target Healthcare REIT plc

LEI:                  213800RXPY9WULUSBC04

Date:                17 October 2025

 

 

Investor Presentation via Investor Meet Company

 

TARGET HEALTHCARE REIT PLC is pleased to announce that Kenneth MacKenzie, Alastair Murray and James MacKenzie of Target Fund Managers, the Company's Investment Manager, will provide a live presentation relating to the Company's Full Year Results via Investor Meet Company on 28 October 2025 at 10:00am GMT.

 

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 09:00am GMT the day before the meeting, or at any time during the live presentation.

 

Investors can sign up to Investor Meet Company for free and add to meet TARGET HEALTHCARE REIT PLC via:

 

https://www.investormeetcompany.com/target-healthcare-reit-plc/register-investor

 

Investors who already follow TARGET HEALTHCARE REIT PLC on the Investor Meet Company platform will automatically be invited.

 

 

 

For further information please contact:       

 

Kenneth MacKenzie; Alastair Murray; James MacKenzie

Target Fund Managers Limited

01786 845 912

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings